我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
1
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
HSA
Health Sciences Authority
<p><strong>4.1 Therapeutic indications</strong></p> <p>XEOMIN is indicated for the treatment of:</p> <ul> <li>Cervical dystonia (spasmodic torticollis) in adults</li> <li>Blepharospasm in adults</li> <li>Spasticity of the upper limb in adults</li> <li>Chronic sialorrhea in patients 2 years of age and older due to neurological disorders</li> </ul> <p>XEOMIN is indicated for the temporary improvement in the appearance of moderate to severe</p> <ul> <li>Upper facial lines <ul> <li>Glabellar frown lines</li> <li>Lateral periorbital lines (crow's feet lines)</li> <li>Horizontal forehead lines</li> </ul> </li> </ul> <p> in adults below 65 years of age.</p>
暂无资讯文章